Cloudera (NASDAQ:CLDR) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, August 9th.

According to Zacks, “Cloudera, Inc. develops and distributes software for business data which include storage, access, management, analysis, security, search, processing and analysis applications. Its products include Cloudera Enterprise Data Hub, Cloudera Analytic BD, Cloudera Operational DB, Cloudera Data Science & Engineering and Cloud Essentials. Cloudera, Inc. is headquartered in Palo Alto, California. “

CLDR has been the topic of several other reports. Morgan Stanley reiterated a “hold” rating and issued a $20.00 target price on shares of Cloudera in a research note on Sunday, May 28th. J P Morgan Chase & Co initiated coverage on shares of Cloudera in a research note on Tuesday, May 23rd. They issued an “overweight” rating and a $24.00 target price for the company. Bank of America Corporation initiated coverage on shares of Cloudera in a research note on Wednesday, May 24th. They issued a “neutral” rating and a $23.00 target price for the company. Citigroup Inc. initiated coverage on shares of Cloudera in a research note on Tuesday, May 23rd. They issued a “neutral” rating and a $23.00 target price for the company. Finally, Deutsche Bank AG started coverage on shares of Cloudera in a research note on Tuesday, May 23rd. They issued a “buy” rating and a $25.00 target price for the company. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $22.86.

Cloudera (NASDAQ:CLDR) traded down 0.40% during trading on Wednesday, hitting $17.48. The company had a trading volume of 264,470 shares. The firm’s 50 day moving average is $17.38 and its 200-day moving average is $18.58. The stock’s market capitalization is $2.29 billion. Cloudera has a 52-week low of $15.40 and a 52-week high of $23.35.

Cloudera (NASDAQ:CLDR) last released its earnings results on Thursday, June 8th. The company reported ($0.27) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.09. The firm had revenue of $79.60 million during the quarter, compared to analysts’ expectations of $75.85 million. On average, equities analysts forecast that Cloudera will post ($1.05) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Zacks Investment Research Lowers Cloudera (NASDAQ:CLDR) to Sell” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/08/19/cloudera-nasdaqcldr-stock-rating-lowered-by-zacks-investment-research-updated.html.

Large investors have recently made changes to their positions in the stock. Nationwide Fund Advisors acquired a new stake in shares of Cloudera during the second quarter valued at about $131,000. Blume Capital Management Inc. acquired a new stake in shares of Cloudera during the second quarter valued at about $135,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Cloudera during the second quarter valued at about $172,000. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Cloudera during the second quarter valued at about $190,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of Cloudera during the second quarter valued at about $190,000.

Get a free copy of the Zacks research report on Cloudera (CLDR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Cloudera (NASDAQ:CLDR)

Receive News & Stock Ratings for Cloudera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cloudera and related stocks with our FREE daily email newsletter.